2024
The impact of overweight and obesity on health outcomes in the United States from 1990 to 2021.
Al Ta'ani O, Al-Ajlouni YA, Aleyadeh W, Al-Bitar F, Alsakarneh S, Saadeh A, Alhuneafat L, Njei B. The impact of overweight and obesity on health outcomes in the United States from 1990 to 2021. Diabetes Obes Metab 2024, 26: 5455-5465. PMID: 39261301, DOI: 10.1111/dom.15924.Peer-Reviewed Original ResearchThe burden of cirrhosis and other chronic liver disease in the middle east and North Africa (MENA) region over three decades.
Al Ta'ani O, Aleyadeh W, Al-Ajlouni Y, Alnimer L, Ismail A, Natour B, Njei B. The burden of cirrhosis and other chronic liver disease in the middle east and North Africa (MENA) region over three decades. BMC Public Health 2024, 24: 2979. PMID: 39468483, DOI: 10.1186/s12889-024-20445-5.Peer-Reviewed Original ResearchDiagnosis and Management of Lean Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A Systematic Review.
Njei B, Ameyaw P, Al-Ajlouni Y, Njei LP, Boateng S. Diagnosis and Management of Lean Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A Systematic Review. Cureus 2024, 16: e71451. PMID: 39544615, DOI: 10.7759/cureus.71451.Peer-Reviewed Original ResearchEfficacy and Safety of GLP-1 Receptor Agonists in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Njei B, Al-Ajlouni Y, Lemos SY, Ugwendum D, Ameyaw P, Njei LP, Boateng S. Efficacy and Safety of GLP-1 Receptor Agonists in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Cureus 2024, 16: e71366. PMID: 39534801, DOI: 10.7759/cureus.71366.Peer-Reviewed Original ResearchRecipient functional status impacts on short and long-term intestinal transplant outcomes in United States adults.
Boateng S, Ameyaw P, Gyabaah S, Adjepong Y, Njei B. Recipient functional status impacts on short and long-term intestinal transplant outcomes in United States adults. World J Transplant 2024, 14: 93561. PMID: 39295973, DOI: 10.5500/wjt.v14.i3.93561.Peer-Reviewed Original ResearchSevere Acute Liver Injury After Hepatotoxic Medication Initiation in Real-World Data
Torgersen J, Mezochow A, Newcomb C, Carbonari D, Hennessy S, Rentsch C, Park L, Tate J, Bräu N, Bhattacharya D, Lim J, Mezzacappa C, Njei B, Roy J, Taddei T, Justice A, Re V. Severe Acute Liver Injury After Hepatotoxic Medication Initiation in Real-World Data. JAMA Internal Medicine 2024, 184: 943-952. PMID: 38913369, PMCID: PMC11197444, DOI: 10.1001/jamainternmed.2024.1836.Peer-Reviewed Original ResearchIncidence rateUS Department of Veterans AffairsMedication initiationDepartment of Veterans AffairsInitiation of medicationVeterans AffairsMain OutcomesPotential of medicationsOutpatient settingDischarge diagnosisCohort studyDay of admissionCase reportReal World DataReport countsMedicationMedical cohortSevere acute liver injuryUS DepartmentFollow-upAcute liver injuryHospitalCohortHepatotoxic medicationsIncidenceImpact of Recipient and Donor Body Mass Index on Survival Outcomes After Intestinal Transplantation: A United Network for Organ Sharing Database Analysis.
Ameyaw PA, Boateng S, Annor EN, Njei B. Impact of Recipient and Donor Body Mass Index on Survival Outcomes After Intestinal Transplantation: A United Network for Organ Sharing Database Analysis. Ann Transplant 2024, 29: e943994. PMID: 38978263, DOI: 10.12659/AOT.943994.Peer-Reviewed Original ResearchAssociation of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) With an Increased Risk of Congestive Heart Failure in Hospitalized Patients With Cirrhosis: A Propensity Score-Matched Analysis.
Ugwendum D, Mohamed M, Al-Ajlouni YA, Nso N, Njei B. Association of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) With an Increased Risk of Congestive Heart Failure in Hospitalized Patients With Cirrhosis: A Propensity Score-Matched Analysis. Cureus 2024, 16: e62441. PMID: 39011212, DOI: 10.7759/cureus.62441.Peer-Reviewed Original ResearchCost-effectiveness analysis: The missing factor in the management of HCC
Njei B, Yi I, Strazzabosco M. Cost-effectiveness analysis: The missing factor in the management of HCC. Clinical Liver Disease 2024, 23: e0178. PMID: 38860130, PMCID: PMC11164007, DOI: 10.1097/cld.0000000000000178.Peer-Reviewed Original ResearchMortality, Hepatic Decompensation, and Cardiovascular- and Renal-Related Outcomes in Lean Versus Non-lean Patients Hospitalized With Metabolic Dysfunction-Associated Steatohepatitis (MASH).
Ezeani C, Omaliko C, Al-Ajlouni YA, Njei B. Mortality, Hepatic Decompensation, and Cardiovascular- and Renal-Related Outcomes in Lean Versus Non-lean Patients Hospitalized With Metabolic Dysfunction-Associated Steatohepatitis (MASH). Cureus 2024, 16: e60968. PMID: 38915982, DOI: 10.7759/cureus.60968.Peer-Reviewed Original ResearchRole of ammonia and glutamine in the pathogenesis and progression of metabolic dysfunction-associated steatotic liver disease: A systematic review.
Njei B, Al-Ajlouni YA, Ameyaw P, Njei LP, Boateng S. Role of ammonia and glutamine in the pathogenesis and progression of metabolic dysfunction-associated steatotic liver disease: A systematic review. J Gastroenterol Hepatol 2024 PMID: 38763916, DOI: 10.1111/jgh.16603.Peer-Reviewed Original ResearchElectrocardiographic Abnormalities in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease: A Systematic Review and Meta-Analysis.
Dimala CA, Nso N, Wasserlauf J, Njei B. Electrocardiographic Abnormalities in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease: A Systematic Review and Meta-Analysis. Curr Probl Cardiol 2024, 102580. PMID: 38653446, DOI: 10.1016/j.cpcardiol.2024.102580.Peer-Reviewed Original ResearchCardiovascular morbidity and mortality in lean vs. non-lean MASLD: A comprehensive meta-analysis.
Nso N, Mergen D, Ikram M, Macrinici V, Hussain K, Lee K, Ugwendum D, Trimingham M, Balasubramanian S, Sam R, Njei B. Cardiovascular morbidity and mortality in lean vs. non-lean MASLD: A comprehensive meta-analysis. Curr Probl Cardiol 2024, 49: 102569. PMID: 38599554, DOI: 10.1016/j.cpcardiol.2024.102569.Peer-Reviewed Original ResearchNovel capsule endoscopy for detecting varices.
Njei B, Al-Ajlouni YA, McCarty TR. Novel capsule endoscopy for detecting varices. BMJ 2024, 384: q506. PMID: 38443073, DOI: 10.1136/bmj.q506.Peer-Reviewed Original Research
2023
The Application of Artificial Intelligence (AI)-Based Ultrasound for the Diagnosis of Fatty Liver Disease: A Systematic Review.
Nduma BN, Al-Ajlouni YA, Njei B. The Application of Artificial Intelligence (AI)-Based Ultrasound for the Diagnosis of Fatty Liver Disease: A Systematic Review. Cureus 2023, 15: e50601. PMID: 38222117, DOI: 10.7759/cureus.50601.Peer-Reviewed Original ResearchGenetic and epigenetic determinants of non-alcoholic fatty liver disease (NAFLD) in lean individuals: a systematic review.
Njei B, Al-Ajlouni YA, Ugwendum D, Abdu M, Forjindam A, Mohamed MF. Genetic and epigenetic determinants of non-alcoholic fatty liver disease (NAFLD) in lean individuals: a systematic review. Transl Gastroenterol Hepatol 2023, 9: 11. PMID: 38317742, DOI: 10.21037/tgh-23-31.Peer-Reviewed Original ResearchClinical and Histopathological Discoveries in Patients with Hepatic Injury and Cholangiopathy Who Have Died of COVID-19: Insights and Opportunities for Intervention
Lim J, Njei B. Clinical and Histopathological Discoveries in Patients with Hepatic Injury and Cholangiopathy Who Have Died of COVID-19: Insights and Opportunities for Intervention. Hepatic Medicine Evidence And Research 2023, 15: 151-164. PMID: 37814605, PMCID: PMC10560482, DOI: 10.2147/hmer.s385133.Peer-Reviewed Original ResearchAcute liver injuryCOVID-19 patientsPre-existing chronic liver diseaseCOVID-19Chronic liver diseaseSARS-CoV-2Immune dysregulationSupportive careBiliary dysfunctionHepatic injuryLiver injuryVascular changesLiver diseaseClinical manifestationsSignificant complicationsLong-term effectsDiagnostic criteriaTherapeutic targetCholangiopathyDiagnostic advancementsPatientsGlobal healthCOVID-19 pandemicInjuryDiverse manifestationsArtificial intelligence in medical imaging for cholangiocarcinoma diagnosis: A systematic review with scientometric analysis
Njei B, Kanmounye U, Seto N, McCarty T, Mohan B, Fozo L, Navaneethan U. Artificial intelligence in medical imaging for cholangiocarcinoma diagnosis: A systematic review with scientometric analysis. Journal Of Gastroenterology And Hepatology 2023, 38: 874-882. PMID: 36919223, DOI: 10.1111/jgh.16180.Peer-Reviewed Original ResearchConceptsConvolutional neural networkArtificial intelligenceComputer visionMedical imagingRole of AIDeep learning algorithmsHigh performance metricsMachine learningSocial network analysisLearning algorithmNeural networkPerformance metricsRelational networksIntelligenceNetworkCholangiocarcinoma diagnosisScientometric analysisVisionNetwork analysisClassifierAlgorithmCollaborationLearningImagesMetricsArtificial intelligence in endoscopic imaging for detection of malignant biliary strictures and cholangiocarcinoma: a systematic review
Njei B, McCarty T, Mohan B, Fozo L, Navaneethan U. Artificial intelligence in endoscopic imaging for detection of malignant biliary strictures and cholangiocarcinoma: a systematic review. Annals Of Gastroenterology 2023, 36: 223-230. PMID: 36864938, PMCID: PMC9932867, DOI: 10.20524/aog.2023.0779.Peer-Reviewed Original ResearchConvolutional neural networkArtificial intelligenceImage processing speedHigh performance metricsPerformance applicationsComputer visionAI classifiersReal-time feedbackNeural networkPerformance metricsProcessing speedIntelligencePerformance measuresClassifierSegmentationMachineNetworkFrameApplicationsWebImagesMetricsVisionRecognitionDatabaseArtificial intelligence for healthcare in Africa: a scientometric analysis.
Njei, B., Kanmounye, U.S., Mohamed, M.F. et al. Artificial intelligence for healthcare in Africa: a scientometric analysis. Health Technol. (2023). https://doi.org/10.1007/s12553-023-00786-8Peer-Reviewed Original Research